Human UPF1: a cap-independent translation initiation mechanism and a cryptic promoter regulate its gene expression in cancer cells by Lacerda, Rafaela et al.
Human UPF1: a cap-independent translation initiation mechanism and a 
cryptic promoter regulate its gene expression in cancer cells 
 
Rafaela Lacerda1,3, Ana Marques-Ramos1,3, Alexandre Teixeira1,2, Luísa Romão1,3 
 
1
Departamento de Genética, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisboa, Portugal 
2
Centro de Investigação em Genética Molecular Humana, Faculdade de Ciências Médicas, 
Universidade Nova de Lisboa, Portugal 
3
Universidade de Lisboa, Faculdade de Ciências, BioFIG – Center for biodiversity, Functional 
and Integrative Genomics, Lisboa, Portugal 
 
 
Cervical (CC) and colorectal (CRC) cancers are among the leading causes of death 
worldwide and their development and progression is dependent on regulation of gene 
expression. Eukaryotic cells possess a variety of post-transcriptional mechanisms by 
which they regulate gene expression, namely at translation initiation level. Although in 
most cases it occurs via the cap-dependent mechanism, several oncogenes, growth 
factors or proteins involved in the regulation of programmed cell death, among others, 
have a different translation initiation mechanism. It involves the direct recruitment of the 
ribosome to the vicinity of the initiation codon without the involvement of the cap 
structure. This allows the maintenance of protein synthesis under several cellular 
stresses and promotes tumourigenesis.  
Apart from its role in nonsense-mediated decay, the human up-frameshift 1 (UPF1) 
DNA and RNA helicase protein plays a crucial role in telomere replication and 
homeostasis, and in cell cycle progression. In addition, its expression levels are 
maintained in every phase of the cell cycle, thus indicating that its translation may 
occur via a cap-independent mechanism. To test this hypothesis, we cloned the human 
UPF1 5’UTR in a dicistronic vector and transfected CC and CRC cell lines with either 
this construct or the control counterparts. We observed a 15- to 25-fold increase in 
relative luciferase activity of the UPF1 5’UTR-containing construct compared to the 
levels obtained from the empty counterpart in all tested cell lines, suggesting a cap-
independent translation initiation. To control whether these levels of luciferase activity 
could be due to the presence of a cryptic promoter, we transfected cells with 
promoterless plasmids and observed the same result, demonstrating that UPF1 5’UTR 
contains a cryptic promoter. To check the cap-independent translation activity alone, 
we transfected cells with in vitro transcribed, capped and polyadenylated mRNAs and 
observed a 2-fold increase in protein levels, which shows that translation can occur in a 
cap-independent way. This is maintained under conditions of global protein synthesis 
inhibition. Deletional analysis of UPF1 5’UTR revealed that first 50 nucleotides are 
essential for both cryptic promoter and cap-independent activities. These results 
provide new insights on the regulation of UPF1 expression in human cancer cells.  
 
